# Yam Nath Paudel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yam-nath-paudel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,399 |
| Field | Neuroscience and Neuropharmacology Research |
| h-index | 33 |
| i10-index | 55 |
| Last Known Institution | Virginia Commonwealth University |
| OpenAlex ID | https://openalex.org/A5083162439 |
| ORCID iD | 0000-0002-8804-6331 |
| Works | 71 |

## Researcher papers

- [HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction](https://scholariq.org/papers/hmgb1-a-common-biomarker-and-potential-target-for-tbi-neuroinflammation-epilepsy/)
- [Revisiting the role of neurotransmitters in epilepsy: An updated review](https://scholariq.org/papers/revisiting-the-role-of-neurotransmitters-in-epilepsy-an-updated-review/)
- [Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting](https://scholariq.org/papers/impact-of-hmgb1-rage-and-tlr4-in-alzheimer-s-disease-ad-from-risk-factors-to/)
- [Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling](https://scholariq.org/papers/enlightening-the-role-of-high-mobility-group-box-1-hmgb1-in-inflammation-updates/)
- [miR-124 and Parkinson’s disease: A biomarker with therapeutic potential](https://scholariq.org/papers/mir-124-and-parkinson-s-disease-a-biomarker-with-therapeutic-potential/)
- [Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy](https://scholariq.org/papers/role-of-inflammation-in-epilepsy-and-neurobehavioral-comorbidities-implication/)
- [Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk](https://scholariq.org/papers/emerging-neuroprotective-effect-of-metformin-in-parkinson-s-disease-a-molecular/)
- [HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities](https://scholariq.org/papers/hmgb1-mediated-neuroinflammatory-responses-in-brain-injuries-potential/)
- [Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders](https://scholariq.org/papers/potential-neuroprotective-effect-of-the-hmgb1-inhibitor-glycyrrhizin-in/)
- [APOE Genotype and Alzheimer’s Disease: The Influence of Lifestyle and Environmental Factors](https://scholariq.org/papers/apoe-genotype-and-alzheimer-s-disease-the-influence-of-lifestyle-and/)
- [Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review](https://scholariq.org/papers/environmental-impact-on-the-epigenetic-mechanisms-underlying-parkinson-s-disease/)

## Researcher topics

- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)
- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Advanced Glycation End Products research](https://scholariq.org/topics/advanced-glycation-end-products-research/)

## Researcher university

- [Virginia Commonwealth University](https://scholariq.org/institutions/virginia-commonwealth-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.